Mitsubishi UFJ Trust & Banking Corp lowered its position in shares of Hologic, Inc. (NASDAQ:HOLX) by 64.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 209,676 shares of the medical equipment provider’s stock after selling 380,078 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned 0.08% of Hologic worth $8,593,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in HOLX. Parnassus Investments CA grew its position in shares of Hologic by 3.4% during the second quarter. Parnassus Investments CA now owns 16,241,334 shares of the medical equipment provider’s stock worth $645,593,000 after acquiring an additional 535,745 shares during the last quarter. Mawer Investment Management Ltd. bought a new position in shares of Hologic during the second quarter worth about $17,025,000. Standard Life Aberdeen plc grew its position in shares of Hologic by 147.0% during the second quarter. Standard Life Aberdeen plc now owns 716,348 shares of the medical equipment provider’s stock worth $28,479,000 after acquiring an additional 426,286 shares during the last quarter. Morgan Stanley grew its position in shares of Hologic by 68.8% during the second quarter. Morgan Stanley now owns 943,536 shares of the medical equipment provider’s stock worth $37,505,000 after acquiring an additional 384,676 shares during the last quarter. Finally, Partner Fund Management L.P. grew its position in shares of Hologic by 20.3% during the second quarter. Partner Fund Management L.P. now owns 1,892,703 shares of the medical equipment provider’s stock worth $75,235,000 after acquiring an additional 319,846 shares during the last quarter. Institutional investors and hedge funds own 91.73% of the company’s stock.

Shares of HOLX stock opened at $43.25 on Friday. The stock has a market capitalization of $12.70 billion, a P/E ratio of 19.39, a PEG ratio of 2.03 and a beta of 0.69. Hologic, Inc. has a 12 month low of $35.10 and a 12 month high of $45.17. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.95.

Hologic (NASDAQ:HOLX) last issued its quarterly earnings data on Wednesday, November 7th. The medical equipment provider reported $0.58 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.59 by ($0.01). Hologic had a negative net margin of 3.46% and a positive return on equity of 23.52%. The business had revenue of $813.50 million during the quarter, compared to analyst estimates of $808.63 million. During the same quarter in the prior year, the firm posted $0.50 earnings per share. Hologic’s revenue for the quarter was up 1.3% compared to the same quarter last year. Equities analysts anticipate that Hologic, Inc. will post 2.4 earnings per share for the current fiscal year.

HOLX has been the subject of several recent research reports. BidaskClub lowered shares of Hologic from a “buy” rating to a “hold” rating in a research report on Thursday, August 9th. Needham & Company LLC restated a “buy” rating and set a $48.00 price target on shares of Hologic in a research report on Monday, August 13th. Canaccord Genuity lowered their price target on shares of Hologic from $42.00 to $41.00 and set a “hold” rating for the company in a research report on Tuesday, August 14th. Deutsche Bank lowered their price target on shares of Hologic from $45.00 to $43.00 and set a “hold” rating for the company in a research report on Monday, August 20th. Finally, Barclays lowered shares of Hologic from an “overweight” rating to an “equal weight” rating and lowered their price target for the stock from $50.00 to $43.00 in a research report on Wednesday, September 5th. They noted that the move was a valuation call. Eleven equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $44.53.

In other Hologic news, CFO Karleen Marie Oberton sold 1,312 shares of the company’s stock in a transaction on Thursday, November 8th. The stock was sold at an average price of $41.90, for a total value of $54,972.80. Following the transaction, the chief financial officer now directly owns 10,206 shares of the company’s stock, valued at approximately $427,631.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Sally Crawford sold 13,257 shares of the stock in a transaction on Monday, September 17th. The stock was sold at an average price of $39.54, for a total value of $524,181.78. Following the sale, the director now directly owns 167,701 shares in the company, valued at $6,630,897.54. The disclosure for this sale can be found here. In the last quarter, insiders have sold 79,276 shares of company stock worth $3,311,802. Company insiders own 0.79% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Mitsubishi UFJ Trust & Banking Corp Sells 380,078 Shares of Hologic, Inc. (HOLX)” was posted by Daily Political and is the property of of Daily Political. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.dailypolitical.com/2018/12/07/mitsubishi-ufj-trust-banking-corp-sells-380078-shares-of-hologic-inc-holx.html.

Hologic Company Profile

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.

See Also: Futures Contract

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.